Withdrawn ID: | w51 |
---|---|
Canonical SMILES: | |
Standard InChI: | |
Standard InChIKey: | |
ATC class(es): | P02CE01 |
Molecular Formula: | C11H12N2S |
Molweight: | 204.291 |
Withdrawn due to drug safety reasons: | Yes |
---|---|
First approved: | 1990 |
First withdrawn: | 1999 |
Last withdrawn: | 1999 |
Reference: | https://www.ncbi.nlm.nih.gov/pubmed/7091125 |
Total reported cases (submitted by medical professionals) with Levamisole as primary suspect: | 11 |
---|
Hospitalization (initial or prolonged): | 5 |
---|---|
Congenital anomaly: | 4 |
Death: | 3 |
Intervention required to prevent permanent impairment/damage: | 1 |
Life-Threatening condition: | 1 |
Disability: | 1 |
Side-effect | Case number |
---|---|
PYREXIA | 4 |
DRUG EXPOSURE DURING PREGNANCY | 3 |
AGRANULOCYTOSIS | 3 |
TOXICITY TO VARIOUS AGENTS | 3 |
SYNDACTYLY | 3 |
SPINA BIFIDA | 3 |
CRYPTORCHISM | 3 |
ACCIDENTAL EXPOSURE | 2 |
CONGENITAL GENITAL MALFORMATION MALE | 2 |
RASH | 2 |
ANTIPHOSPHOLIPID ANTIBODIES POSITIVE | 2 |
BLOOD ALBUMIN DECREASED | 1 |
BLOOD BILIRUBIN INCREASED | 1 |
CANDIDIASIS | 1 |
CELLULITIS | 1 |
Completed suicide | 1 |
ARTHRALGIA | 1 |
DRUG ADMINISTRATION ERROR | 1 |
MENTAL STATUS CHANGES | 1 |
ELECTROCARDIOGRAM QT PROLONGED | 1 |
INTERNATIONAL NORMALISED RATIO INCREASED | 1 |
JOINT EFFUSION | 1 |
LEUKOENCEPHALOPATHY | 1 |
Leukopenia | 1 |
WHITE BLOOD CELL COUNT DECREASED | 1 |
NEUTROPENIA | 1 |
OFF LABEL USE | 1 |
Oral infection | 1 |
Pain | 1 |
PERITONSILLAR ABSCESS | 1 |
PLATELET COUNT DECREASED | 1 |
PNEUMONIA | 1 |
RENAL FAILURE ACUTE | 1 |
SINUS TACHYCARDIA | 1 |
Skin graft | 1 |
Vasculitis | 1 |
VENTRICULAR FIBRILLATION | 1 |
Toxicity class: | 3 |
---|---|
Toxicity type: | hematological |
LD50: | 138 mg/kg |
ChEBML: | CHEMBL1454 |
---|---|
DrugBank: | DB00848 |